| Main focus of clinical study |
Number |
| Using CB for specific hematological disorders |
22 |
| Conditioning regimen |
22 |
| Use of cellular therapy (e.g. T-cells) post-CB transplantation |
9 |
| Use of expanded CBU |
9 |
| Combined use of CB and Haploidentical grafts |
7 |
| Use of unlicensed CBUs |
5 |
| Direct intra-bone infusion of CB |
4 |
| Combined use of two CBU |
3 |
| Co-infusion of CBU with accessory cells (MSC/Tregs) |
3 |
| Use of growth factors (Eltrombopag) post-UCB transplant |
3 |
| UCB vs. Haploidentical transplantation |
2 |
| Improved homing of UCB HSC |
2 |
| T-cell depletion of CBU |
2 |
| Fucosylation of CB HSC |
1 |
| Management of GvHD infection post-CB transplantation |
2 |
| Total clinical trials |
96 |
